Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway.

Cristiani CM, Turdo A, Ventura V, Apuzzo T, Capone M, Madonna G, Mallardo D, Garofalo C, Giovannone ED, Grimaldi AM, Tallerico R, Marcenaro E, Pesce S, Del Zotto G, Agosti V, Costanzo FS, Gulletta E, Rizzo A, Moretta A, Karre K, Ascierto PA, Todaro M, Carbone E.

Cancer Immunol Res. 2019 May;7(5):841-852. doi: 10.1158/2326-6066.CIR-18-0651. Epub 2019 Apr 2.

PMID:
30940644
2.

Meeting the Challenge of Targeting Cancer Stem Cells.

Turdo A, Veschi V, Gaggianesi M, Chinnici A, Bianca P, Todaro M, Stassi G.

Front Cell Dev Biol. 2019 Feb 18;7:16. doi: 10.3389/fcell.2019.00016. eCollection 2019. Review.

3.

Author Correction: MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state.

Poli V, Fagnocchi L, Fasciani A, Cherubini A, Mazzoleni S, Ferrillo S, Miluzio A, Gaudioso G, Vaira V, Turdo A, Gaggianesi M, Chinnici A, Lipari E, Bicciato S, Bosari S, Todaro M, Zippo A.

Nat Commun. 2018 Sep 20;9(1):3921. doi: 10.1038/s41467-018-06480-y.

4.

MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state.

Poli V, Fagnocchi L, Fasciani A, Cherubini A, Mazzoleni S, Ferrillo S, Miluzio A, Gaudioso G, Vaira V, Turdo A, Gaggianesi M, Chinnici A, Lipari E, Bicciato S, Bosari S, Todaro M, Zippo A.

Nat Commun. 2018 Mar 9;9(1):1024. doi: 10.1038/s41467-018-03264-2. Erratum in: Nat Commun. 2018 Sep 20;9(1):3921.

5.

Role of Type I and II Interferons in Colorectal Cancer and Melanoma.

Di Franco S, Turdo A, Todaro M, Stassi G.

Front Immunol. 2017 Jul 26;8:878. doi: 10.3389/fimmu.2017.00878. eCollection 2017. Review.

6.

IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition.

Gaggianesi M, Turdo A, Chinnici A, Lipari E, Apuzzo T, Benfante A, Sperduti I, Di Franco S, Meraviglia S, Lo Presti E, Dieli F, Caputo V, Militello G, Vieni S, Stassi G, Todaro M.

Cancer Res. 2017 Jun 15;77(12):3268-3279. doi: 10.1158/0008-5472.CAN-16-3126. Epub 2017 Apr 11.

7.

Squamous Cell Tumors Recruit γδ T Cells Producing either IL17 or IFNγ Depending on the Tumor Stage.

Lo Presti E, Toia F, Oieni S, Buccheri S, Turdo A, Mangiapane LR, Campisi G, Caputo V, Todaro M, Stassi G, Cordova A, Moschella F, Rinaldi G, Meraviglia S, Dieli F.

Cancer Immunol Res. 2017 May;5(5):397-407. doi: 10.1158/2326-6066.CIR-16-0348. Epub 2017 Mar 28.

8.

ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis.

Di Franco S, Turdo A, Benfante A, Colorito ML, Gaggianesi M, Apuzzo T, Kandimalla R, Chinnici A, Barcaroli D, Mangiapane LR, Pistone G, Vieni S, Gulotta E, Dieli F, Medema JP, Stassi G, De Laurenzi V, Todaro M.

Oncotarget. 2016 Aug 23;7(34):54157-54173. doi: 10.18632/oncotarget.11022.

9.

miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance.

De Cola A, Volpe S, Budani MC, Ferracin M, Lattanzio R, Turdo A, D'Agostino D, Capone E, Stassi G, Todaro M, Di Ilio C, Sala G, Piantelli M, Negrini M, Veronese A, De Laurenzi V.

Cell Death Dis. 2015 Jul 16;6:e1823. doi: 10.1038/cddis.2015.192.

10.

Tumor and its microenvironment: a synergistic interplay.

Catalano V, Turdo A, Di Franco S, Dieli F, Todaro M, Stassi G.

Semin Cancer Biol. 2013 Dec;23(6 Pt B):522-32. doi: 10.1016/j.semcancer.2013.08.007. Epub 2013 Sep 4. Review.

PMID:
24012661
11.

Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy.

Todaro M, Turdo A, Bartucci M, Iovino F, Dattilo R, Biffoni M, Stassi G, Federici G, De Maria R, Zeuner A.

Cancer Res. 2013 Nov 1;73(21):6393-400. doi: 10.1158/0008-5472.CAN-13-0248. Epub 2013 Sep 5.

Supplemental Content

Support Center